Company registration number 00533303 (England and Wales)
PANDECT INSTRUMENT LABORATORIES LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
PANDECT INSTRUMENT LABORATORIES LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
PANDECT INSTRUMENT LABORATORIES LTD
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
181,553
188,905
Current assets
Stocks
31,200
31,200
Debtors
5
311,817
311,818
343,017
343,018
Creditors: amounts falling due within one year
6
(3,500)
(3,500)
Net current assets
339,517
339,518
Total assets less current liabilities
521,070
528,423
Provisions for liabilities
(34,495)
(47,226)
Net assets
486,575
481,197
Capital and reserves
Called up share capital
4,000
4,000
Revaluation reserve
7
116,473
116,473
Profit and loss reserves
366,102
360,724
Total equity
486,575
481,197

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements. true

The financial statements were approved by the board of directors and authorised for issue on 29 June 2026 and are signed on its behalf by:
Mr R Pope
Director
Company registration number 00533303 (England and Wales)
PANDECT INSTRUMENT LABORATORIES LTD
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2026
31 March 2026
- 2 -
1
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

2
Accounting policies
Company information

Pandect Instrument Laboratories Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Wellington Road, Cressex Business Park, High Wycombe, Buckinghamshire, HP12 3PX.

2.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

2.2
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
2% Straight Line
Plant and equipment
15% Reducing Balance
Fixtures and fittings
15% Reducing Balance
Computers
25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

PANDECT INSTRUMENT LABORATORIES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
2
Accounting policies
(Continued)
- 3 -
2.3
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

2.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

2.5
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

2.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

PANDECT INSTRUMENT LABORATORIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
2
Accounting policies
(Continued)
- 4 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

2.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

2.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

PANDECT INSTRUMENT LABORATORIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 5 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
2
2
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2025 and 31 March 2026
346,368
254,538
600,906
Depreciation and impairment
At 1 April 2025
160,224
251,777
412,001
Depreciation charged in the year
6,927
425
7,352
At 31 March 2026
167,151
252,202
419,353
Carrying amount
At 31 March 2026
179,217
2,336
181,553
At 31 March 2025
186,144
2,761
188,905
5
Debtors
2026
2025
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
311,817
311,818
6
Creditors: amounts falling due within one year
2026
2025
£
£
Other creditors
3,500
3,500
7
Revaluation reserve
2026
2025
£
£
At the beginning and end of the year
116,473
116,473
PANDECT INSTRUMENT LABORATORIES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 6 -
8
Parent company

The ultimate controlling party is Pandect Precision Components Limited a company registered in England and Wales.

2026-03-31 2025-04-01 false false false 30 June 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr R Pope Mrs H Pope S Todd 00533303 2025-04-01 2026-03-31 00533303 2026-03-31 00533303 2025-03-31 00533303 core:LandBuildings 2026-03-31 00533303 core:OtherPropertyPlantEquipment 2026-03-31 00533303 core:LandBuildings 2025-03-31 00533303 core:OtherPropertyPlantEquipment 2025-03-31 00533303 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 00533303 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 00533303 core:ShareCapital 2026-03-31 00533303 core:ShareCapital 2025-03-31 00533303 core:RevaluationReserve 2026-03-31 00533303 core:RevaluationReserve 2025-03-31 00533303 core:RetainedEarningsAccumulatedLosses 2026-03-31 00533303 core:RetainedEarningsAccumulatedLosses 2025-03-31 00533303 bus:Director1 2025-04-01 2026-03-31 00533303 core:LandBuildings core:LeasedAssetsHeldAsLessee 2025-04-01 2026-03-31 00533303 core:PlantMachinery 2025-04-01 2026-03-31 00533303 core:FurnitureFittings 2025-04-01 2026-03-31 00533303 core:ComputerEquipment 2025-04-01 2026-03-31 00533303 2024-04-01 2025-03-31 00533303 core:LandBuildings 2025-03-31 00533303 core:OtherPropertyPlantEquipment 2025-03-31 00533303 2025-03-31 00533303 core:LandBuildings 2025-04-01 2026-03-31 00533303 core:OtherPropertyPlantEquipment 2025-04-01 2026-03-31 00533303 core:CurrentFinancialInstruments 2025-03-31 00533303 core:CurrentFinancialInstruments 2026-03-31 00533303 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 00533303 bus:FRS102 2025-04-01 2026-03-31 00533303 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 00533303 bus:Director2 2025-04-01 2026-03-31 00533303 bus:CompanySecretary1 2025-04-01 2026-03-31 00533303 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 00533303 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP